LV10568B - Device for oral feeing of active substance to animals and method for preparation thereof - Google Patents
Device for oral feeing of active substance to animals and method for preparation thereof Download PDFInfo
- Publication number
- LV10568B LV10568B LVP-93-1232A LV931232A LV10568B LV 10568 B LV10568 B LV 10568B LV 931232 A LV931232 A LV 931232A LV 10568 B LV10568 B LV 10568B
- Authority
- LV
- Latvia
- Prior art keywords
- casing
- binder
- active substance
- shell
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Housing For Livestock And Birds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Description
3JIEMEHT JPH ΟΡΑΜΟΓΟ BBE^EHMH ΜΒΟΊΉΗΜ ΑΚΤΜΒΗΟΓΟ BEilļECTBA Η CIIOCOB ΕΓΟ ΓΜΉΕΗΜΗ.
OnHcaHHe Μ3ο6ρβτβΗΗβ othochtch κ 3JieM6HTaM, coflepjKau],™ aKTHBHoe BerqecTBO, Tanoe nan ββκι^μηβι, MeftMKaMeHT03HBie BeiņecTBa hjih aHajiorH^HBie cpe,n,CTBa, npe,n,Ha3HaiieHHBte flJin ββθαθηηη hx nepe3 ροτ flOMamHHM HJIH flHKHM JKHBOTHBIM. ΠρββΜΘΤΟΜ Η30(5ρβΤβΗΗΗ flBJIH-θτοη TaKwe cnocoč noJiyHeHHH yKa3aHHBix ajieMeHTOB. ^aiqe Bcero ΒΒβ,ηβΗΗθ jieKapcTB flOMainHHM jkhbothbim np0H3B0-flHTOH napoHTepaJībHo, nocjie τογο, Kan ηχ πρκΒβ,π,γτ b ΗβποβΒΗΚ-ΗΟβ COCTOHHHe. 2
Ecjih KMBOTHbie nacyTCH Ha BOJie, to tiacTO τργ^Ηο h ,ε^κθ onacHo y^ep?KHBaTb hx, WTOdbi ββθοτη hm BaKLļHHy hjih jieKapcTBa. riOHMKa HeCKOJIbKHX ,Π,ΗΚΗΧ HCHBOTHbDC ΗΜΘΘΤ Τθ ΚΘ Tpy,H1HOCTH Η τοτ »e pncK, oflHaKo HepeajībHO JienHTb Bcex κηβοτηηχ ο^ηογο η τογο ate BH,n,a Ha onpeflejieHnoft τθρρκτορΗΗ b HHln,HBnļiiyajibHOM no-pnflKe.
Ehjih paspaOoTaHH θλθμθητβι, co^epacaisHe JieKapCTBeHHtie cpefl— CTBa H KOTOpbIM 6bIJI npHflaH npMBJieKaTeJIbHblfi flJIH JKHBOTHbDC BHfl JļJEH OpaJIbHOrO ΒΒΘ,Π,ΘΗΗΗ. 3τΚ 3ΠΘΜΘΗΤΗ paCnpefleJIHJIHCb Ha ČOJIb-ιπηχ τθρρΗτορππχ, Tax ^to<5h mojkho dbuio jienHTb 3HaHHTejibHoe ko-JIHtieCTBO ,Π,ΗΚΗΧ ΚΚΒΟΤΗΒΙΧ, a TaKKe ΤΘΧ in,OMamHHX HCHBOTHbDC, KOTO-pbK ΗΘ ΧΟΤΗΤ HJIH ΗΘ MOryT nOHMaTb.
Pi3 θΒροπΘΗΟκοίί 33ηβκη EP-A-240826 HsaecTeH cnocod nojiytie- HHH npHMaHKH, COrJiaCHO KOTOpOMy B $OpMy ΒΒΟ,Π,ΗΤ BenļeCTBO, odpa-3yiomee nojļjiojKKy, BKJiicmafomee b cedn jiHnHflHoe semecTBO, areHT ^jih CTadHJiH3aiļHH φορΜΗ, a TaKJKe aTTpaKTKBHoe h BOsdļDKflaioiiļee anneTHT y μβοτηηχ ΒβιςθοτΒΟ, saTeM Ha nojiyneHHbiH cjioh HaHOCHT aKTHBHoe ΒθίςβοτΒΟ, 3aTeM CHOBa bboaht BemecTBo noflJiojKKH ajih ΠΟΚρΗΤΗΗ HM aKTHBHOTO BeiIļeCTBa.
Tanofl cnocod κμθθτ onpe^eJieHHoe hkcjio He^ocTaTKOB. Ββθ,π,θ-ηηβ b JiHTbeByio $opMy προ^κτοΒ Tpe(5yeT πρημθηθηηη flocTaTonHO TeKyqero BemecTBa npn TeMnepaType pa3JiHBa h ecjiH χοτητ, nTodbi 3Ta TeMnepaTypa (5buia οοβμθοτημο c coxpaHeHHeM aKTHBHoro βθήθοτ-Ba, TO ΗΘ0(5Χ0βΗΜ0 πρΗΜΘΗΗΤΒ BeiIjeCTBa, y K0T0pbIX TOHKa nJiaBJieHHH HaxojļHTCH b6jih3h npe#eJibHbix TeMnepaTyp πρημθηθηηη. OflHaKO, no-flOČHOe ΟΓρΟΗΗΗΘΗΗΘ ΠΠΟΧΟ OTpasaeTCH Ha CTaČHJIbHOCTH npHMaHKH. ΚροΜβ τογο, pa3JiHB Be^eCTBa 3a ,n,Ba 3Tana μοικθτ πρηβθοτη κ xpyn-kogtk 3JieMeHTa, ^ocTaTO^iHO c^ecTBeHHofi Ha ypoBHe ctuko , tjto npn MajiOH MexaHH^ecK0fi nponHOCTH BeņecTBa CTaHOBHTCH ηθβο3μο«-hhmh Hcnojib30BaHHe οοΒρβΜθΗΗΒΐχ μθτο,π,οβ pacnpocTpaHeHHH Kancyj[ B <50JIbIHHX MaCHITaOaX, B naCTHOCTH, πρπ ΠρΗΜΘΗΘΗΗΗ aBHanļHQHHbIX ΜΘΤΟ,Π,ΟΒ.
Tokhm o6pa30M, ijejibio HacTOHmero Η30(5ρθΤθΗΗΗ ηβιεηθτοη pa3pa-dOTKa 3JIGMeHT0B ,Π,-ΠΗ OpaJIbHOrO ΒΒΘ,Π,ΘΗΗΗ JKHBOTHHM, ΚΟΤΟρΗΘ ΟβΗΟ-ΒρβΜθΗΗΟ dbuiH dbi npHBJieKaTeJibHbi h B03dy)KflajiH dbi anneTHT .iļjih .E^aHHOrO 5ΚΜΒΟΤΗΟΓΟ, ΗΜΘΗΗ 6bl BbICOKyiO MexaHHH6CKyiO H TepMHHeCKyK) LV 10568 3 npO^HOCTb, H rOflHJIHCb ČBI flJIH paBdpaCBIBaHHH 0 B03^yxa- npH Bcex KJiHMaTHyecKHX ycjioBHHX b 3οηθ pacnpefl-ejieHHfl.
Enje o,n,Ha i^ejib ΗβοβρβτβΗΗΗ coctoht b tom, ^itoOh TaKne 3Jie- ΜβΗΤΒΙ dbUIH 6h ,Π,βΠΙβΒΒΙΘ Η ΛβΓΚΗβ B Η3Γ0Τ0ΒΛΘΗΗΗ<, a TaKJKe flOCTa- to^iho CTOMKHe κ cTapeHHK) b toM cpe^e, r^e ohh pacnpocTpaHHJOTcn, 3a flocTaTO^HO dojibmoft nepnoļ, ΒρβΜβΗΗ. JĻih flocTHHceHHH 3T0& ujsjm 3aHBHTeJib npefljraraeT βλθμθητ flJifl OpaJībHOrO ΒΒΘ,ΙΙ,βΗΗΗ HCHB0THB1M, npe^CTaBJinjūtņuM codofi 060JI0^Ky, BHyTpH κοτοροίί Haxo^HTCH aKTHBHoe BeniļecTBO, aaKJuo^aroinHMCH b tom, wto odoJio^Ka coflepscHT χοροπιο nepeMemaHHBie ο^,ηο hjih Hec-kojībko B03Čy}Kflaioipx anneTHT BemecTB h ο,β,ηο hjih HecKOJibKo βθ-ιςβοτΒ fljiH arjiOMepupoBaHHH yriOMHHyTUx BenjecTB, npimeM odojio^na npeflBapMTeJIbHO C$0pM0BaHa B BHfle nOJIOfi φορΜΒΙ, ΠΟΑΧΟβΗΗίθΗ flJIH noTpedjieHHH jkhbothbimh BHyTpeHHHfi ο6τ>θμ, κοτορΒίΚ 3anoJiHeH BH3H-BaioinHM anneTHT CBfl3yromHM, coflepmamHM aKTHBHoe BenjecTRo, h npn-jieraranļHM κ. BHyTpeHHefi ποΒβρχΗοοτπ odojio^KH, τθμ caMbiM odecne^H-Ban HenpepHBHOCTb MeK,ny OČOJIOtiKOM H yKa3aHHBIM aKTHBHBJM BemeCTBOM. ripeflno^TMTejibHO, odojio^Ka ημθθτ Tpyd^aTyio $opMy, b ^acTHOC-th, napajuiejiennneAHyK3 $opMy. npeHMymecTBeHHo, odojio^Ka Μ0«βτ deTb ΓΗ,π,ροφοόΗΟίί Jindo 3a c^eT πρΗΜβΗβΗΜΗ. arjiOMepnpyniņHX ΓΗ,ηροφοβΗΒΐχ MaTepnajioB, Jindo 3a CtieT ΒΒΘ,Π,ΘΗΗΗ ΓΗ,Π,ροφοβΗΒΙΧ .DļOdaBOK, Τ3ΚΗΧ, KaK MaCJIO H T.JĻ, CBH3yiomnM MaTepna;i, BH3biBaioinHH anneTHT, μοικθτ dbiTb noflodeH MaTepnajiy odojiomai. npeAno^THTeJibHo, stot MaTepiiaji flOjraeH odjia- .aaTb OflHHM, HeCKOJIbKMMH MJIH ΒΟΘΜΗ yKa3aHHBIMH ΗΗΚΘ CBOKCTBaMH: - TepMOCTOMKOCTblO, - ynpyrocTbK> hjih njiacTK^HocTbio ,π,-πή yBejiwyeHHH yn,apHoft npo^-hocth 3JieMeHTa b LjeJiOM, - ΓΗΑρθφθ^ΗΟΟΤ5Ι), - noHBJiHTbca Ha ποΒβρχΗΟΟτκ, b tiacTHOCTH, Kor^a odojmKa
Tpyd^aTan.
JlenapcTBO μο?κθτ HaxoflHTbCH b θμκοοτη, HanpHMep, b ueinovKe, Kancyjie κ τ.β., hjih m b BHfle TadJieTKH.
JleKapcTBO μο?κθτ 6bitb pacnpefleJieHO b cBH3yraņeM MaTepnajie hjih nepeMemaHO c hhm.
JlenapcTBO μοκθτ 6βιτβ b τβθρ^ομ hjih κκ,ςκοΜ cootohhhh. 4
Αγθητ BučupaioT H3 cjie,ņyioiiiHX BemecTB: nojiHOSHflbi (nojincaxa-pHflti), KpaxMajiH, iļejunoji03a, pacTHTeJibHbie hjih «ηβοτηηθ bockh, CHJIHKOHbl, ΘΗΗΤβΤΗηβΟΚΗΘ nOJIHMeptr, B naCTHOCTH, JKHpHHe KHCJIOTH c ,π,ΛΗΗΗΟίί iļen-bK), npeflno^THTeJibHO Ū£q hjih čojiee h ΐ.β. Αγθητομ arjiOMepaiļHH μοκθτ Čutb, b nacTHOCTH, nojiKMep TKna τβχ, κοτορπθ npHMeHHKTCH B COCTaBe KOpMa flJIH ΚρθΒΘΤΟΚ Η pbl(5 B ΟΟΟΤΒΘΤΘΤΒΗΗ c naTeHTaMH ^^5*4576821, 4666717, 4741904, HanpHMep, 3THJieH-BHHHJiaiļeTaTH.
OčoJio^Ka b θοοτβθτθτβηη c Κ3θβρθΤθΗΗβΜ μοκθτ, HanpHMep, ημθτβ cocTaB, onHcaHHHit b naTeHTax ΟΠΙΑ, hjih sce cocTaB, hbjihio-DļHHCH KOpMOM flJIH ΚρθΒΘΤΟΚ , KOTOpbīH ΠρΟ^ΘΤΘΗ IlOfl Ha3BaHHeM
ΚΡΑΥβΟ ( ckawdeaux) aMepHKaHCKOH φκρΜΟίί ^ļEOnOH JPEMyP. JļjIH JIHC H COČaK npHMaHKa ΜΟΚβΤ ΚΜβΤΒ ΠρβΑΠΟηΤΗΤβϋΒΗΟ flJIH-Hy 50 mm, ϋίκρΗΗγ 32 mm h TOJin],HHy 20 mm, a nojiocTb b Tpy6naTOH οόοηοηκθ μοικθτ ημθτβ ,n,JiHHy 50 mm, niHpHHy 23 mm h BHCOTy 9 mm. B ΘΟΟΤΒΘΤΘΤΒΗΗ C OCOČblM CnOCOČOM peaJIH3aBļHH Η3θ6ρθΤΘΗΗΗ B πρκ-MaHKe ΜΟΙΚΘΤ ΗΜΘΤΒΘΗ ΗΘΤΟΚθΗΗΗΗβ MapKep, HanpHMep, aHTHČMOTHK xjīoprHflpaT-TeTpau1HKJiHHa. Ποθλθ^ηηη μοκθτ Haxo,n,HTbCfi b odojion-κβ H3 pac^eTa 150 μγ Ha o,n;Hy npHMaHKy. Πρθ,ηΜΘΤΟΜ Η3θ6ρθΤΘΗΗΗ HBJIH6TCH TaKKe CnOCO<5 nOJiyneHHH Ta-ΚΗΧ 3ΛΘΜΘΗΤ0Β, OTJIHnaiOIHHiiCH ΤΘΜ, nTO φορΜ^Τ o60J10HKy H3 CMe-ch T^aTeJibHO nepeMemaHHbix ο,π,ηογο hjih ηθθκο;ιβκηχ ΒθίςθθΤΒ, B03-6y7KflaioiiļHX anneTHT h OflHoro hjih HecKOJibKHx areHTOB arjiOMepaijHH, B036y7K^aiomHx anneTHT βθ^θθτβ, npn $opMOBaHHH odojionKe npH.n.aiOT nojiyio $opMy, bo BHyTpeHHHft ο<5ί>θμ κοτοροπ noMenjaiOT aKTHBHoe βθ-DļecTBo h CBH3y»mee, B036yE,nlafomee anneTHT, Tan ητο(5π CBH3yK>mee npnjierajio κ BHyTpeHHeft φορΜθ odojionKH. ripeflnonTHTeJibHO, očojion-κθ npH^aioT Tpy<5tiaTyio φopMy, b nacTHOCTH, napajuiejienHneflHyB. 06o jionKa μοκθτ ημθτβ Jiio6yK) noflxoflHmyro φopMy, b nacTHOCTH, iļHJiHH,npH necKyio. ūpeflnonTHTeJibHO, o6ojionKy H3roTOBJiHioT 3KCTpy3neM. B nepBOM npe,n,nonTHTeJibHOM cnocode peajiH3aLļHH H30(5peTeHHH aKTHBHoe sen^ecTBO noMeiiļaioT bo BHyTpeHHK)io nojiocTb odojionKH, 3a-τθμ Ty^a HajiHBaioT CBH3yiomee BeiqecTBO.
Bo ΒτοροΜ npeflnonTHTejibHOM cnocoče peajiH3aqHH Η3θ6ρβτθΗΗΗ BHyTpeHHK3io nojiocTb odojionKH aajiHBaioT cBH3yK)n^HM, co^epKaii^HM aKTHBHoe BemecTBO. LV 10568 5
CriOCOO B C00TB6TCTBMH C Η3θ6ρβΤΘΗΗΘΜ ΜΟΚΘΤ ČbITb ΛΘΓΚΟ ΠρΗ-ΜΘΗβΗ B npOMBIinJieHHOCTH.
Il0JiyyeHHbIH 9THM ΜΘΤΟ,ϋ,ΟΜ BJīeMeHT ΜΟΚΘΤ XpaHHTE>CH πρκ KOMHaT-hoK' TeMnepaType hjih npn ΗΗ3κοίί TeMnepaType, b 3Εβηοημοοτη ot τρβ ČOBaHHE B ΟΤΗΟΙΠΘΗΗΗ XpaHeHMH ΒΚΤΗΒΗΟΓΟ BeiIļeCTBa.
Hrae M3o6peTeHne 6yp,eτ onnoaHO OoJiee ποβροδΗΟ npn noMonpi npuMepa, HJunocTpnpyioinero cnocoč β οοοτβθτοτβηη c η3ο(5ρθτθηηθμ, co ccHJiKOfi Ha npHJiaraeMHe pncyHKn, r^e: . Ha phc.I noKa3aH nonepenHbift paspe3 aJieMeHTa, nojiynaeMoro no cn-oco(5y β οοοτβθτοτβηη c η3ο6ρθτθηηθμ,
Ha pnc.2 noKa3aH npoflOJibHbīft paope3 no jihhhh ΙΜΙ Ha pnc.I,
Ha pnc.3 noKa3aH npojļOJibMtt pa3pe3 no jihhhh IĪĪ-IĪĪ Ha pnc»! CHanajia η3γοτββληββιοτ Tpy6naTyio očoJionKy I μθτο^ομ 3KCTpy-3hh npn I00°C. Jķn 3KCTpy3HH 6epyT CMecb pnčbero rcupa, nopMa flJIfl- pbl6 H 3THJieH-BHHHJiaiļeTaTa Β ΠρΟΠΟρίξΗΗΧ, ΠρΘ,ϋ,ΠΟΗΤΗΤβΛΒΗΗΧ no yKa3aHHHM naTeHTaM CllIA.
Pa3Mepn o-6ojiohkh I BHOnpaiOT b 3aBHCHMOCTH ot BH#a hchbothldc, flJI-fl κοτορυχ ΓΟΤΟΒΗΤ 0JI6M6HTbl. ilocjie οχηηκ,π,θΗΗΗ o6ojiοηκπ I (očojionica οτηοοητθλβηο acecTKaa h 0Ha ΓΗ^,ροφοβΗηΗ) η nojiyneHHH Tpe(5yeMoK flJiHHbi očojiohkh, b no-JiocTb odojionKH πομθπ^κτ μθιιιοηθκ 2 H3 njiacTHnecKoro MaTepnana (TepM03anHHHHft πο-πηθτη,πθη) , b κοτοροΜ Haxo,n,nTCH βκτηβηοθ BemecT-bo (HanpnMep, npothbonyMHan BaKiļHHa) β οΟβθμθ 2,5 mji. . 3aTeM b 3Ty nojiocTb BJineaioT CBH3yioinee 3 β βη,π,θ ομθοη rapoB, κοτοροβ ημθθτ HeBbicoKyio TeMnepaTypy nJiaBJieHHH, ocTaeTCH nacTO-0(5pa3HbiM πρπ βηοοκηχ TeMnepaTypax η ηθ TpecKaeTca πρπ ηηβκηχ TeMnepaTypax. B 3Ty ομθοβ stnpoB βχο^ητ Taioue npHMaHHBaiomee h Bbi3HBaiomee anneTHT BemecTBO y flaHrioro BHfla «ηβοτηηχ. ΦΗ3ΗηΘΟΚΜΘ CBOMCTBa H CTaOHJIbHOCTb.
McnHTaHHH Ha TeMnepaTypHyio οτοΑκοοτβ ot -20°C ,π,ο +45°C no-Ka3anH, ητο CTpyKTypa oneMeHTa, nojiyneHHoro, kbk onncaHO Bbnne, coxpaHHJiacb b 3tom HHTepBajie TeMnepaTyp. Πρπ stoh nocjieflHefi TeMnepaType CBH3yioinee ημθθτ nacTOodpa3Hyio κοΗΟΗΟΤθΗηπκ), KOTopaa ηθ cHHsaeT θφφθκτΗΒΗοοτπ Ojiaro^apa ctohkocth oOojiohkh.
McnHTaHHH Tanse noKaaajiH BbicoKyio yaapHyio nponHocTb npn pa3-dpacbiBaHHH e BOpTOJieTa c bhcoth 6ojiee 100 m Ha 6eTOHHyio ποΒθρχ- 6 HOCTb, ΠρΗ 0TOM HH OflHH ΘΛΘΜΘΗΤ ΗΘ ,pa3pyiHHJICfl.
BhJIM TaKTKe ΠρΟΒβββΗΗ HCIIHTaHHH C IļeJIbK) OlļeHHTb θφφβΚΤΗΒΗΟΟΤΒ cpe^CTBa b οοοτβθτοτβμη c Η3θ6ρβτθΗΗβΜ y JiHCMiļ h codaK. Ποϋγ^βΗ-ηηθ pe3yjibTaTH noKa3ajiH xopomyio npuBJieKaTeJibHOCTb npHMaHKH ,ιι,λη jKKBOTHbDC, a CTpyKTypa npHMaHKH 0Ka3a;iacb ocodeHHO djiaronpHHTHOH ,ηΛΗ θΦΦθκτηβηογο ycBoeHHH aKTHBHoro BemeCTBa (xopomee BHflejieHHe KHflKOrO aKTHBHOrO BemeCTBa B pOTOBOH nOJIOCTH). ATTpaKTHBHbie CBofiCTBa. īlepBLiK omiT npoBOflHJiCH Hafl 10 codaKaMH, πομθπ1θηηημρϊ b hh^h-BH,nyajibHHe doKCH. Kaiflaa codaica nojiymna θλθμθητ b οοοτβθτοτβηη c H3odpeTeHneM (cnocod nojiytieHHH, onncaHHHH BHme), "κοτορΒίΜ ομθ-niHBajiH c KopMOBtiM paiļHOHOM. Hepe3 24 vaca nocjie paarami 6hjio norJIOIIļeHO 100% ΘΛβΜβΗΤΟΒ Η ΠρΗΜβΗΗΘΜΗΗ IļBeTOBOft MapKep n03B0JIHJI c^ejiaTb 3aKJncweHHe, tiTO co,n,ep)KaHKe Memomca nonajio b iviOTKy 9 codaK H3 10. Βτοροίί οπητ dbiJi npoBefleH c 18 codaKaMH πρκ τεχ sce yc;iOBHHX H npHBeJi κ TaKHM me pe3yjibTaTaM. ΚροΜβ τογο, Te codaKH, κοτορΗΜ .naBajm b cjiefl^īpe ,ηΗΗ I hjih 2 3JieMeHTa b οοοτβθτοτβηη c H3odpeTeHneM, Bce hx πογ\ποτη.τιη 3a οροκ 24 ^aca. ΟφφβΚΤΗΒΗΟΟΤΒ. ΟφφβΚΤΗΒΗΟΟΤΒ npOBepHJiaCb B paMKaX npOTHBO^iyMHOM BaKLļHHaiļHH nJIOTOHflHBK ΚΗΒΟΤΗΗΧ *ίβρβ3 pOT C Π0Μ0Π1ΒΚ) 3.7ΙβΜΘΗΤΟΒ, ΟΟβθρΗίεΐΐρϊΧ Β Ka^ecTBe BaKiļHHH peKOMdHHaT BaKiļHHa/πΐΗκοπροτβΗΗ G, βκτηβηοοτβ κοτοροΗ yiKe dbuia flOKa3aHa. 18 pmnx jmcmļ dtuiH pa3fleJieHH Ha-3 rpynna (A, B, C) no 6 ocodefi, Kaffi^oe κηβοτηοθ HaxoflHJiocb b HHflHBH,nyajibHofī KJieTKe.
Tpynna A nojiyqajia I θλθμθητ β αθηβ 0 (J\0). rpynna B nojiy^ajia 2 3JieMeHTa (b fleHb 0 h ,n,eHb I) (Jļ0) η (βΐ).
Tpynna C nojiy^ajia 3 BJieMeHTa (/10, β1 h JI£). 4 JIHCHIļH dHJIH OCTaBJieHbī B Ka^eCTBe KOHTpOJIbHbDC. y KajKflOH JIHCHLļH 3a Η3ΜΘΗβΗΗβΜ COflepJKaHHfl ΠρΟΤΗΒΟ^^ΜΗΒΙΧ aHTHTeJI. %pe3 28 flHeft nocjie BaKiļHHaiļHH dmia npoBe^eHa BHyTpnMHinetiHaH npoBepna (BnpyjieHTHaH fl03a yyMHoro snpyca).
Bce HeBaKiļHHnpoBaHHbie KOHTpojibHbie ocodu dbuin MepTBH. LV105S8 7
Pe3yji&TaTbi πρΜΒβββΗΒΐ b cJieflyiomefĪ TadJiHiļe: CTeneHb KOHBepCKH CBJBOpOTKK CTeneHb 3anļHTH rpynna A 4 5 rpynna B 5 6 rpynna C 5 5 ΑηΘΛΟΓΉ^ΗΒΙ-Μ ΟΠΒΙΤ 6bIJI ΠρΟΒΒ,Π,βΗ C 18 CO(5aKaMH, KOTOpBIM ΗΜΚΟΓ,Πφ ηθ BBOflKJiacb npoTHBOtiyMHaH CBiBopoTKa, Tpynna A no;iynajia I θλθμθητ b fleHb'0 (,110), rpynna B - 2 eJieMeHTa b fteHb 0 (flO) h fleHb 3 (1β), a rpynna C nojiynajia 3 BJieMSHTa b ahh 0, 3 h 4 (β0, jļ3, Jļ4), CTeneHb KOHBepcHH CBiBopoTKH dtuia cjiejiyiOiqeii: - rpynna A - 5,' - rpynna B = 6, -,rpynna C = 6.
Cnocod B COOTBeTCTBHH C Η3θ6ρθΤβΗΗβΜ ΜΟΤΚΘΤ ΠρΗΜβΗΗΤΒΟΗ flJIH noJiytieHHH 3JieMeHT0B KaK ajia αηκηχ mbothbk, TaK h ajih ,n,OMaiiiHMX JKHBOTHBK. MOJKHO nepe^HCJlHTb TaKHX ΚΜΒΟΤΗΒΙΧ: JIKCHIļBr, XOpbKH, ΘΗΟ-TBij maKajiH., ,ο,κκκβ coČaKH,, kohikh,''.HanpMMep,. ββθλθηηθ BaKiļHH προτΗΒ nyMbi , a Tax®e flOMamHne κμβοτηηθ TaKHe, KaK (5hkh, KpynHHH poraTBift CKOT, OBIļBI, K03BI, JIOEia^H, CBKHbH, COČaKH, ΚΟΙΠΚΗ H T.fl. Εοτθοτβθηηο, aKTHBHoe BemecTBO MOsceT <5βιτβ TaKace τβθρ,κημ, n0p0EIK006pa3HBlM KJIH naCTOO(5pa3HBIM. 0hO Μ05ΚΘΤ npeACTaBJIHTb co(5oh BaKiļHHy, aHTudnoTHK, ropMOH, aHTHnapa3HTapHoe cpe^CTBO' h T.fl.
KaK 9to cjie,n,yeT cawo no cede, H30<5peTeHHe ηθ orpamraKBaeTCH onncaHHBiM cnocočoM peajiH3aiļHH, ho 0XBaTbiBaeT BapnaHTBi, ηθβθθτηηθ cneiļMajiHCTaM.
Claims (7)
- LV 10568 Izgudrojuma nosaukums: "Elements aktīvas vielas oralai ievadīšanai dzīvniekiem un paņēmiens tā iegūšanai" Pateritformulas punkti 1. Elements apvalkā ievietotas aktīvās vielas orālai ievadīšanai dzīvniekiem, kas atšķiras ar to, ka apvalks izgatavots no vienas vai vairākām ēstgribu ierosinošām vielām maisījumā ar vienu vai vairākiem aģentiem minēto vielu saistīšanai, tā iekšējais tilpums piepildīts ar aktīvo vielu saturošu apetīti rosinošu saistvielu, kas pieguļ apvalka iekšējai virsmai un nodrošina apvalka un minētās aktīvās vielas nedalāmību. 2. P®c Pun^ta 1, kas atšķiras ar to, ka apvalkam ir cauruļveida vai paralelpipeda forma.
- 3. Elements pēc punkta 1 vai 2, kas atšķiras ar to, ka apvalks ir hidrofobs. t. 4. pēc punktiem 1-3, kas atšķiras ar to, ka apvalkā ievadīta piedeva, kas padara to hidrofobu. 5. ĒlĒŪĪĒDi® Pēc punktiem 1 -4, kas atšķiras ar to, ka saistvielas materiāla sastāvs ir analogs apvalka sastāvam. 6. pēc punktiem 1-5, kas atšķiras ar to, ka saistvielas slānis veidots no siltumizturīga materiāla.
- 7. Elements pēc punktiem 1-6, kas atš. ķiras ar to, ka apvalka slānis un saistvielas slānis veidoti no elastīga materiāla 8. pēc punktiem 1 - 7, kas atšķiras ar to, ka apvalka slānis un saistvielas slānis ir plastiski.
- 9. Elements pēc punktiem 1-8, kas atšķiras ar to, ka saistvielas slānis veidots no hidrofoba materiāla. 10. pēc punktiem 1-9, kas atšķiras ar to, ka saistviela izdalās uz virsmas. 11. P®c punktiem 1-10, kas atšķiras ar to, ka aktīvā viela iepildīta tilpnē. 12. Pēc punktiem 1 - 11, kas atšķiras ar to, ka aktīvā viela izkliedēta vai sajaukta ar saistvielu. 13. elementa pēc punkta 1 iegūšanai, kas atšķiras ar to, ka veido dobu apvalku no vienas vai vairākām ēstgribu izsaucošām vielām, kas rūpīgi sajauktas ar vienu vai vairākiem minētās vielas saistošiem aģentiem, apvalka iekšpusē ievie to aktīvo vielu un ēstgribu rosinošu saistvielu tādā veidā, lai sais tviela piegulētu apvalka· iekšējai virsmai. 14. ?§2§!!!iĒns P®° Pun^ta 13, kas a t š,-ķ iras ar to, ka apvalkam piedod cauruļveida formu.
- 15. Paņēmiens pēc punkta 13, kas atšķiras ar to, ka apvalku veido ar ekstrūziju.
- 16. Paņēmiens pēc Punkta 13, kas atšķiras ar to, ka aktīvo vielu ievieto apvalka iekšienē un pēc tam nodrošina aktīvās vielas noturēšanos apvalkā, ielejot tajā saistvielu.
- 17. Paņēmiens pēc punkta 13, kas atšķiras ar to, ka apvalka iekšienē ielej saistvielu, kas satur aktīvo vielu.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8912831A FR2652501B1 (fr) | 1989-10-02 | 1989-10-02 | Elements therapeutiques pour l'administration orale d'un medicament aux animaux et procede de fabrication. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10568A LV10568A (lv) | 1995-04-20 |
| LV10568B true LV10568B (en) | 1995-10-20 |
Family
ID=9385990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-93-1232A LV10568B (en) | 1989-10-02 | 1993-11-15 | Device for oral feeing of active substance to animals and method for preparation thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5747063A (lv) |
| EP (1) | EP0421863B1 (lv) |
| AT (1) | ATE99926T1 (lv) |
| CA (1) | CA2026505C (lv) |
| CZ (1) | CZ284021B6 (lv) |
| DD (1) | DD298057A5 (lv) |
| DE (1) | DE69005965T2 (lv) |
| FR (1) | FR2652501B1 (lv) |
| HU (1) | HU208480B (lv) |
| LT (1) | LT3822B (lv) |
| LV (1) | LV10568B (lv) |
| PL (1) | PL165904B1 (lv) |
| RU (1) | RU2038830C1 (lv) |
| SK (1) | SK280260B6 (lv) |
| UA (1) | UA26429A (lv) |
| ZA (1) | ZA907658B (lv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6753004B2 (en) * | 2001-09-04 | 2004-06-22 | Auburn University | Biodegradable fishing lure and material |
| US6716448B2 (en) | 2001-10-05 | 2004-04-06 | Rubicon Scientific Llc | Domesticated household pet food including maintenance amounts of ivermectin |
| US6866862B2 (en) * | 2001-10-05 | 2005-03-15 | Rubicon Scientific | Animal feeds including heartworm-prevention drugs |
| US7052712B2 (en) * | 2001-10-05 | 2006-05-30 | Rubicon Scientific Llc | Animal feeds including actives and methods of preparing same |
| US7067142B2 (en) * | 2002-01-22 | 2006-06-27 | S.C. Johnson & Son, Inc. | Packaged rodenticide |
| US20040091579A1 (en) * | 2002-11-13 | 2004-05-13 | Rubicon Scientific Llc; | Extruded foodstuffs having maintenance level actives |
| US20060218848A1 (en) * | 2005-03-29 | 2006-10-05 | Terry Melhorn | Scent releasing/absorbing system for an in-line, rotating fishing chum and/or fishing scent dispenser |
| BRPI0720667A8 (pt) | 2006-12-27 | 2017-04-25 | Pfizer Prod Inc | Métodos de administração de vacina |
| WO2012032182A1 (en) | 2010-09-10 | 2012-03-15 | Idt Biologika Gmbh | Oral veterinary preparations |
| WO2012145577A1 (en) | 2011-04-20 | 2012-10-26 | Merial Limited | Adjuvanted rabies vaccine with improved viscosity profile |
| EP3215188A1 (en) | 2014-11-03 | 2017-09-13 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| US11654107B2 (en) | 2019-06-03 | 2023-05-23 | JMN Technologies LLC | Animal treat composition for delivery of oral medication |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3607295A (en) * | 1968-10-18 | 1971-09-21 | Dee R Morgan | Plastic moldable composition useful as a fish bait |
| FR2032164A5 (en) * | 1969-02-20 | 1970-11-20 | Pasteur Institut | Muskrat poison bait |
| US3829564A (en) * | 1970-07-17 | 1974-08-13 | Commw Scient Ind Res Org | Coated products for veterinary use |
| FR2144599A1 (en) * | 1971-07-07 | 1973-02-16 | Henry Jacques | Veterinary compsns - of substances absorbed by solid porous carriers, for dosing dogs |
| DE3367500D1 (de) * | 1982-02-26 | 1987-01-02 | Ciba Geigy Ag | Rodenticidal bait |
| US4666717A (en) * | 1985-07-12 | 1987-05-19 | E. I. Du Pont De Nemours And Company | Long life semi-artificial bait |
| US4576821A (en) | 1985-07-12 | 1986-03-18 | E. I. Du Pont De Nemours And Company | Long life semi-artificial bait |
| US4741904A (en) | 1985-07-12 | 1988-05-03 | E. I. Du Pont De Nemours And Company | Long life semi-artificial water borne feed |
| CA1249518A (en) * | 1985-09-06 | 1989-01-31 | David Johnston | Oral immunization of mammals |
| DE3611122A1 (de) * | 1986-04-03 | 1987-10-15 | Klocke Hartmut | Koeder fuer tiere |
| DE68910886D1 (de) * | 1988-06-17 | 1994-01-05 | Du Pont | Pestizide Zusammensetzungen. |
-
1989
- 1989-10-02 FR FR8912831A patent/FR2652501B1/fr not_active Expired - Lifetime
-
1990
- 1990-09-25 ZA ZA907658A patent/ZA907658B/xx unknown
- 1990-09-26 DD DD90344222A patent/DD298057A5/de not_active IP Right Cessation
- 1990-09-28 CA CA002026505A patent/CA2026505C/fr not_active Expired - Lifetime
- 1990-10-01 UA UA4831254A patent/UA26429A/uk unknown
- 1990-10-01 CZ CS904775A patent/CZ284021B6/cs not_active IP Right Cessation
- 1990-10-01 PL PL90287140A patent/PL165904B1/pl unknown
- 1990-10-01 RU SU904831254A patent/RU2038830C1/ru active
- 1990-10-01 AT AT90402713T patent/ATE99926T1/de not_active IP Right Cessation
- 1990-10-01 EP EP90402713A patent/EP0421863B1/fr not_active Expired - Lifetime
- 1990-10-01 SK SK4775-90A patent/SK280260B6/sk not_active IP Right Cessation
- 1990-10-01 DE DE90402713T patent/DE69005965T2/de not_active Expired - Lifetime
- 1990-10-02 HU HU906301A patent/HU208480B/hu unknown
-
1992
- 1992-06-11 US US07/896,905 patent/US5747063A/en not_active Expired - Fee Related
-
1993
- 1993-11-15 LV LVP-93-1232A patent/LV10568B/lv unknown
-
1994
- 1994-01-13 LT LTIP1766A patent/LT3822B/lt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US5747063A (en) | 1998-05-05 |
| LTIP1766A (en) | 1995-07-25 |
| DE69005965T2 (de) | 1994-05-05 |
| PL165904B1 (pl) | 1995-03-31 |
| HU208480B (en) | 1993-11-29 |
| UA26429A (uk) | 1999-08-30 |
| FR2652501B1 (fr) | 1992-01-10 |
| HUT58985A (en) | 1992-04-28 |
| CS9004775A2 (en) | 1991-10-15 |
| HU906301D0 (en) | 1991-04-29 |
| PL287140A1 (en) | 1991-09-23 |
| ATE99926T1 (de) | 1994-01-15 |
| CA2026505A1 (fr) | 1991-04-03 |
| EP0421863A1 (fr) | 1991-04-10 |
| SK280260B6 (sk) | 1999-10-08 |
| ZA907658B (en) | 1991-07-31 |
| CA2026505C (fr) | 2000-06-20 |
| DE69005965D1 (de) | 1994-02-24 |
| LV10568A (lv) | 1995-04-20 |
| LT3822B (en) | 1996-03-25 |
| RU2038830C1 (ru) | 1995-07-09 |
| EP0421863B1 (fr) | 1994-01-12 |
| DD298057A5 (de) | 1992-02-06 |
| CZ284021B6 (cs) | 1998-07-15 |
| FR2652501A1 (fr) | 1991-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV10568B (en) | Device for oral feeing of active substance to animals and method for preparation thereof | |
| Marinelli et al. | Carvacrol and its derivatives as antibacterial agents | |
| JP5530060B2 (ja) | 免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法 | |
| ES2086029T3 (es) | Composiciones farmaceuticas solidas para la administracion oral con permanencia gastrica prolongada. | |
| BR9907647A (pt) | Composições contendo composto orgânicos | |
| AU3113893A (en) | Flavour-masked pharmaceutical compositions | |
| ES2104522T3 (es) | Nuevo sistema de administracion de medicamento. | |
| ZA200901075B (en) | Pharmaceutical composition | |
| DE60230308D1 (de) | Mischung aus propionibacterium jensenii und lactobacillus sp. mit antimikrobiellen eigenschaften undtel | |
| IL169769A (en) | Anthracycline-antibody conjugates | |
| CA2408716A1 (en) | Stable polymeric micelle-type drug composition and method for the preparation thereof | |
| CY1105026T1 (el) | Συστημα χορηγησεως φαρμακου : συνθεση δια λιπο-διαλυτα φαρμακα | |
| ATE345775T1 (de) | Zusammensetzungen zur verabreichung von arzneimittelkombinationen | |
| Villa et al. | New weapons to control bacterial growth | |
| MX2008001532A (es) | Composicion farmaceutica que contiene indometacina y/o acemetacina. | |
| WO1992018111A3 (en) | Pharmaceutical composition for the treatment of gastritis | |
| IE46306B1 (en) | Safeguarded toxic chemical compositions containing an emetic | |
| WO2003045305A3 (en) | Acetaminophen compositions | |
| DK122190D0 (da) | Phospholipid-indesluttet cationisk, lipofilt farmaceutisk praeparat og fremgangsmaade til fremstilling af samme | |
| ATE302014T1 (de) | Immunstimulierende bakterienwandfraktionen zur krebsbehandlung | |
| WO1994016723A3 (en) | Wound healing composition | |
| Khilnani et al. | Learning pharmacology by metaphors: A tale of aminoglycosides | |
| GB9815801D0 (en) | Liquid polymeric compositions for controlled released bioactive substances | |
| US20220087933A1 (en) | Pet Treat Pocket | |
| Walker et al. | Parenteral toxicity |